AMAG PHARMACEUTICALS INC's ticker is and the CUSIP is 00163UAD8. A total of 34 filers reported holding AMAG PHARMACEUTICALS INC in Q3 2017. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $14,000 | +16.7% | 15,000 | 0.0% | 0.00% | – |
| Q2 2020 | $12,000 | 0.0% | 15,000 | 0.0% | 0.00% | – |
| Q1 2020 | $12,000 | -52.0% | 15,000 | -50.0% | 0.00% | – |
| Q4 2019 | $25,000 | -99.1% | 30,000 | -99.1% | 0.00% | -100.0% |
| Q3 2019 | $2,934,000 | -12.2% | 3,521,000 | -16.7% | 0.00% | 0.0% |
| Q2 2019 | $3,343,000 | -8.4% | 4,225,000 | -0.4% | 0.00% | 0.0% |
| Q1 2019 | $3,650,000 | -22.5% | 4,244,000 | -17.0% | 0.00% | 0.0% |
| Q4 2018 | $4,712,000 | -26.2% | 5,116,000 | -16.1% | 0.00% | 0.0% |
| Q3 2018 | $6,386,000 | -32.9% | 6,096,000 | -33.4% | 0.00% | -50.0% |
| Q2 2018 | $9,513,000 | +73.8% | 9,152,000 | +72.2% | 0.00% | +100.0% |
| Q1 2018 | $5,472,000 | -2.4% | 5,315,000 | -17.6% | 0.00% | 0.0% |
| Q4 2017 | $5,605,000 | +0.1% | 6,448,000 | +11.3% | 0.00% | 0.0% |
| Q3 2017 | $5,602,000 | – | 5,794,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Mohican Financial Management, LLC | 1,500,000 | $1,492,000 | 2.87% |
| Telemetry Investments, L.L.C. | 8,000,000 | $7,780,000 | 2.78% |
| Context Capital Management, LLC | 3,500,000 | $3,405,000 | 2.28% |
| Kamunting Street Capital Management, L.P. | 2,500,000 | $2,431,000 | 1.54% |
| BASSO CAPITAL MANAGEMENT, L.P. | 12,205,000 | $11,824,000 | 1.46% |
| TENOR CAPITAL MANAGEMENT Co., L.P. | 17,500,000 | $17,269,000 | 1.34% |
| CAMDEN ASSET MANAGEMENT L P /CA | 32,375,000 | $31,485,000 | 1.04% |
| Jabre Capital Partners S.A. | 5,500,000 | $5,328,000 | 1.04% |
| City Financial Investment Co Ltd | 12,500,000 | $12,168,000 | 0.77% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 16,250,000 | $15,747,000 | 0.71% |